Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04273724 · ClinicalTrials.gov registry record · NA

Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT04273724 is a NA study that was terminated before completion, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04273724, a NA study, was terminated before completion, sponsored by UNC Lineberger Comprehensive Cancer Center.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

A Comprehensive Geriatric Assessment (CGA) is a set of tests used to evaluate a patient's medical, social, and functional status, and can identify impairments in these domains that may not be noticed otherwise. Prior studies have shown that a CGA can accurately predict which patients are more likely to have serious side effects from cancer treatment. However, it is unknown whether interventions can be done to address the impairments found during a CGA in order to reduce the risk of these side effects. This pilot study will test the feasibility of targeted interventions for deficits identified during a CGA in patients 65 years or older with bladder cancer that have not yet started treatment.

Interventions

  • OTHER Targeted Interventions for Impairments Identified During Geriatric Assessment

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2020-01-21
Est. Completion 2021-09-29
Phase NA

What the Registry Record Tells You About NCT04273724

The ClinicalTrials.gov registry entry for NCT04273724 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Targeted Interventions for Impairments Identified During Geriatric Assessment is the first listed.

NCT04273724 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04273724 about?

NCT04273724 is a clinical study titled "Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder Cancer". A Comprehensive Geriatric Assessment (CGA) is a set of tests used to evaluate a patient's medical, social, and functional status, and can identify impairments in these domains that may not be noticed otherwise. Prior studies have shown that a CGA can accurately predict which patients are more likely...

What is the current status of trial NCT04273724?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2020-01-21. Estimated completion is 2021-09-29.

What interventions are being tested in trial NCT04273724?

The interventions under investigation include: Targeted Interventions for Impairments Identified During Geriatric Assessment (OTHER).

Who is sponsoring clinical trial NCT04273724?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.